Startups
DomainMarket.com sells premium domain names to entrepreneurs, businesses, and nonprofits that want to dominate their online marketplaces and perpetually control great brands.
Overview
Employees
11-50
Total raised
$76M
Founded date
2009
Funding Rounds 4
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jan 28, 2014 | Series C round | $14M | |
| Jun 12, 2012 | Series C round | $33M | |
| Jun 11, 2010 | Funding round | $24M |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 28, 2014 | Igenica Raises $14M in Series C Financing | Igenica, Inc., a Burlingame, CA-based biotherapeutic company, raised $14m in Series C extension financing. Backers include major current investors The Column Group, 5AM Ventures, OrbiMed and Third Rock Ventures. Led by chief executive offic... |
| Jun 12, 2012 | Igenica Raises $33M in Series C Funding | Igenica, Inc., a Burlingame, CA-based biopharmaceutical company developing antibody-based cancer medicines, has raised $33m in Series C round of funding. The round was led by new investor Third Rock Ventures, with participation from existin... |
| Jun 12, 2012 | Igenica Secures $33M Series C | BURLINGAME, CA, Leading biopharmaceutical company focused on the discovery and development of first-in-class antibodies, announced that it has raised $33 million in a Series C round >> Click here for more funding data on Igenica &... |
| Jun 11, 2010 | Igenica Completes $24M Financing Round | Igenica, Inc., a Burlingame, CA-based biopharmaceutical company developing innovative antibody-based cancer medicines, has completed a $24m Series B financing round. The round was led by The Column Group, OrbiMed Advisors and 5AM Ventures. ... |
| Antibody drug conjugate player Igenica Biotherapeutics raises $5M | Igenica Biotherapeutics – a biotech star-studded with execs that, in previous career incarnations brought a number of antibody drug conjugate drugs to market – just raised a modest round of funding to further develop its own ADCs. The Bay A... |